Abstract-The coming era of personalized cancer treatment is presenting automation with unprecedented opportunities. Currently, the drug susceptibility test of clinical cancer patients is mainly dependent on manual labor with a low level of automation. Automating the process of primary cancer cell detection will potentially have tremendous economic benefits and social significance. Automated cancer cell detection means developing robotic and automation equipments to handle single cells and molecules at the micro/nanometer-scale. The achievements of information science, engineering technology, life sciences, and nanotechnology in the past decades have led to the birth of robots that can perform effective manipulations on single living cells at the micro/nanometerscale in aqueous conditions, opening the door to automated cancer cell detection. However, there is still a huge gap between current single-cell micro/nano automation technology and clinical requirements for personalized medicine. In this paper, we will review the progress of single-cell micro/nano automation technology in recent years and discuss the facing challenges and future directions in three aspects, including automated cell isolation and delivery, automatically acquiring the physiological features of cells and data analysis.
the major cause (more than 90%) of cancer-related deaths is tumor metastasis [4] . In the past 20 years, antibody-based targeted therapy has become one of the most successful and important strategies for treating patients with haematological malignancies and solid tumors [5] , [6] . More than 25 monoclonal antibodies have been approved worldwide and novel monoclonal antibodies are entering clinical study at a rate of nearly 40 per year [7] . The wide use of antibodies in clinical practice produces huge profits for pharmaceutical industry. Despite the unprecedented success of antibodies in cancer treatment, there are still many patients who are not sensitive or develop resistance to antibodybased therapy [8] . In addition, the cost of antibody therapy is relatively high (nearly $3,000 per infusion) and it can induce various side effects which can sometimes be serious [9] . Hence, how to recognize the patients that may potentially achieve benefits from the targeted therapy has become a challenge. Addressing this challenge requires us to test and analyze the cancer cells from individual patients, which will be of active significance for the coming era of personalized precision medicine [10] .
Robotics and automation (R&A) technology has played an extremely important role in the progress of human civilization. A famous example is the automotive industry, where full robot automation is usually found for car body assembly, press tending, painting, coating and to some extent for engine and power assembly [11] , considerably improving the efficiency of automotive production since 1970s [12] . In recent years, many autonomous robotic systems at the microscale have been developed for diverse biomedical applications, such as assembly of vascular-like microtube [13] , 3D morphological and mechanical characterization of single plant cells [14] , cell motility analysis [15] , cellular sample preparation [16] , tissue-and organ-level physiology [17] , and drug discovery [18] . The applications of R&A technology conversely promote the development of automation science and engineering. Now the requirements of personalized cancer diagnosis & treatment present automation with new opportunities. Currently, clinical drug susceptibility tests for individual patients are mainly dependent on manual labor, involving several steps (e.g., biopsy tissue extraction, cell culturing, tumor cell isolation & identification, drug addition, again cell culturing, and diverse biochemical assays) and each step takes a long time (often several days) [19] . If the time of clinical drug susceptibility test can be shortened by introducing automation technology, it will undoubtedly be of important significance for personalized cancer treatment.
However, automating clinical drug susceptibility test for personalized medicine is challenging. The first issue is the objects being handled. In the targeted therapy, monoclonal antibodies bind to the surface molecules (e.g., antigen, ligand) specifically expressed on tumor cells [6] , which can then deplete the tumor cells via immune mechanisms. An example is rituximab (a monoclonal antibody approved in 1997 by US Food and Drug Administration) in the therapy of B-cell non-Hodgkin lymphoma. The binding of rituximab to the CD20s on the lymphoma cell can cause the death of lymphoma cell via three main mechanisms [20] , including directly inducing cell apoptosis, causing cell lysis via complement system, and recruiting effector cells (e.g., macrophage and NK cell) to attack tumor cells. Various molecular interactions take place during the actions of rituximab. Hence in order to better understand the efficacies of drugs, probing the target molecules on the cell surface is indispensable. This means that for automated drug susceptibility test, robotic and automation equipments are developed to handle single cells and cellular molecules whose sizes are in the range of micrometer and nanometer [21] , and thus this is called micro/nano automation. The second issue is the cellular heterogeneity. In the pipeline of automotive industry, the automotive parts are designed manually and have the same sizes, which facilitates the industrial robots to perform repetitive tasks. Cells are highly heterogeneous [22] and different cells have different properties (e.g., shape, density, size, stiffness, deformability), meaning that the objects being manipulated by micro/nano robots are very unstructured. Besides, cells are dynamic (various metabolic activities take place within cells during the life of cells), which results in the temporal heterogeneity. Investigating cellular variability has recently been considered to be a new era in molecular biology, which can reveal novel regulatory mechanisms for cellular processes [23] . The daunting challenge in life sciences is to determine which components of the observed cellular heterogeneity serve a biological function or contain meaningful information [24] . Consequently, cellular variability present difficulties when applying micro/nano automation technology in drug susceptibility test for personalized cancer treatment, and to our knowledge so far these issues have not been well addressed from the perspective of automation. Nevertheless, in the past decades, various techniques emerged as building blocks for micro/nano automation technology, providing possibilities for automating the process of detecting cancer cells from the clinical patients.
II. BLUEPRINT OF MICRO/NANO AUTOMATION IN PERSONALIZED CANCER TREATMENT
Since human sensing, precision, and size are not sufficient to interact with biological cells and access micro/nanometer spaces directly, micro/nano-robotics has emerged as a new robotics field to extend our manipulation, interaction, and exploration capabilities to micro/nanometer scales [25] . Since 1959 in the Nobel physicist Richard P. Feynman's prescient talk "There's plenty of room at the bottom", tiny nanorobots that could be designed, manufactured, and introduced into human body to perform cellular repairs at the molecular level have been imagined [26] . Currently, it is challenging to fabricate a nanorobot capable of performing even a simple medical task by traditional engineering method [27] , but biological nanomaterials can be used to construct complex "machinery" capable of actuation, propulsion, sensing, computation, and decision making [28] . In 2012, Douglas et al. [29] used DNA molecules to create a nanorobot (35 nm × 35 nm × 45 nm) which can deliver drugs to target cancer cells and the results showed that nanorobots can induce a variety of tunable changes in cell behavior, practically opening the door to nanorobotic medicine, such as killing cancer cell, cleaning clogged arteries, repairing tissues, and crushing stones that form inside organs [30] . The other type of nanorobot is a large robot that can be used to manipulate nanosized objects, often called a nanomanipulator [31] . The overall nanomanipulator system size can be very large, while only the manipulation tools, manipulated objects, and sensing, actuation, and manipulation precision are required to be at the nanoscale [25] . Nanomanipulator systems are constructed by using new material, fabrication, sensing, actuation, control, and assembly techniques due to the new situations (such as new physics, scaling effects, quantum effects and precision requirements) at the nanoscale [32] . So far typical nanomanipulators are based on scanning electron microscopy (SEM), environmental SEM (ESEM) or atomic force microscopy (AFM) [33] [34] [35] . The disadvantage of SEM-based nanomanipulator is that it requires the sample dried and fixed, meaning that it cannot handle living cells. Though ESEM can manipulate samples containing some moisture, there is still a big gap between the conditions in ESEM (0°C, 600 Pa pressure) [33] and the real environments (37°C, standard atmosphere) living cells reside in. Currently, living cells cannot be observed by ESEM under the physiological conditions [36] . In contrast, AFM can work in liquids, enabling robotic manipulations on single living cells under physiological conditions [37] , such as drug injection [38] , nanodissection [39] , nanoindentation [40] and nanovisualization [41] . Hence, AFM-based nanomanipulator is particularly suited for biological applications at the nanometer scale.
In the past decade, significant progress has been achieved in the robotic manipulation of single cells at the micrometer scale [42] . Inspired by the flagella of bacteria, in 2009, Zhang et al. [43] developed a swimming robot that had a comparable size to a bacterium (micrometer scale). The swimming robot consisted of an artificial bacterial flagellum (ABF) attached to a magnetic 'head'. The locomotion of ABF was precisely controlled by orthogonal electromagnetic coil pairs, showing the potential to be used for medical and biological applications (e.g., drug delivery, killing cancer cell) in aqueous environments (such as in human body). Future challenges include the powering and steering technology for microrobots inside the body, how to detect, localize and communicate with microrobots inside the body, how to make and integrate on-board diagnostic and therapeutic tools, and how to program and control armies of microrobots (as this will be necessary if such robots are to treat large areas of the body) [44] . The other type of microrobot is a large robot that can be used to manipulate single cells, often called a micromanipulator [45] . Since the pioneer work of Sun and Nelson [46] , a number of automated robotic system have been developed for diverse applications at the single-cell level, including capture, immobilization, deposition, patterning and injection of cells [47] , [48] , greatly promoting the applications of microrobotic systems in biology and medicine.
The achievements in micro/nano robot and micro/nano manipulator in the past decade allow us to conceive applying micro/nano automation technology in detecting cancer cells for personalized diagnosis & treatment, and the blueprint presented in this paper is shown in Fig. 1 . After preparing the clinical biological samples (e.g., biopsy tissues acquired by surgery, bone marrow acquired by aspiration, and peripheral blood extracted from vessels) from clinical patients, cancer cell isolation methods are applied to collect cancer cells which are then delivered to the micro/nano automation pipeline. Micro/nano robots and micro/nano manipulators automatically perform sequential manipulations on the cells in the pipeline. Like industrial robots in the automation pipeline of automotive industry, each micro/nano robot or micro/nano manipulator performs a specific task, e.g., delivering or injecting drugs onto/into the cell, indenting the cell, visualizing the cellular structures, and probing the target molecules on cell surface. After the robotic manipulations, the detection results of each cell in the pipeline are recorded. By modeling the process of robotic detection and analyzing the detection data, quantitative cellular features (e.g., surface roughness, surface topography, mechanical properties, and target molecules' properties) are obtained. By inputting these quantitative parameters into the database and according to the relation models, the changes of cellular biological functions (e.g., viability, proliferation, the ability of deformation, adherence and locomotion [49] ) are acquired, which are then used for drug evaluation and doctor decision making (e.g., recognizing the potential sensitive drugs for the patient). After decision making, the potential sensitive drugs are used for the clinical therapy of the patient. In the past few years researchers have carried out investigations on the issues listed in Fig. 1 and obtained notable progress. In the following sections, we will summarize these progress and discuss the challenges in applying micro/nano automation technology to detect cancer cells for personalized cancer treatment.
III. AUTOMATED CELL ISOLATION AND DELIVERY
For the drug susceptibility test of cancer patients, the prerequisite is acquiring the patients' biological samples, such as biopsy tissues obtained by surgery, bone marrow obtained by aspiration, and blood. These clinical biological samples are composed of healthy cells and cancer cells. For automated drug susceptibility test, methods that can automatically isolate the cancer cells from healthy cells are required. Traditional methods for cell isolation are mainly based on fluorescent activated cell sorting (FACS) and magnetic activated cell sorting (MACS) [50] . For FACS, shear flow focuses fluorescently-labeled cells which are then excited by a laser and given a specific charge based upon the fluorescent dye color. Cells are then collected into containers via an electric field. For MACS, target cells labeled with magnetic beads pass through a magnetic field, during which non-target cells could flow out of the magnetic field while target cells retain in the magnetic field. After removing the magnetic field, target cells are collected. The main drawback of applying FACS and MACS in micro/nano automation is that they require a time-consuming and manual-dependent procedure to pretreat specimens (e.g., labeling, centrifugation, washing), which impedes the fidelity of subsequent cell assay and does not meet the demands of automated cell isolation. Microfluidics, a technology characterized by the engineered manipulation of fluids at the submillimetre scale [51] , has shown considerable promise for automatically isolating cancer cells from clinical samples. Cell sorting devices based on microfluidics have many advanced features, including faster sorting rates, equal or improved accuracies, ability to process native biological fluids, simpler operating procedures enabling fully automated systems, reduced cost, reduced biohazard risk by eliminating aerosols, etc [52] .
Tumor metastases are the cause of approximately 90% of human cancer-related deaths [53] . Because the dissemination of tumor mostly occurs through the blood, circulating tumor cells (CTCs) that have been shed into the vasculature and may be on their way to potential metastatic sites are of obvious interest [54] . CTCs have been shown to be effective biomarkers in [60] and (d) size filtration [61] . (e), (f) Label-free microfluidics isolating CTCs by acoustic waves [62] and optically-induced electrophoretic (ODEP) force [63] .
prognosis and predicting drug sensitivity in clinical cancer therapy [55] . Hence, collecting CTCs from the blood of cancer patients is of important significance in personalized medicine. CTCs are rare, comprising as few as one cell per 10 9 haematologic cells in the blood of patients with metastatic cancer, and thus their isolation presents a tremendous technical challenge [56] . In 2007, Nagrath et al. [56] developed a unique microfluidic platform (CTC-chip) capable of efficient and selective separation of viable CTCs from peripheral whole blood samples, as shown in Fig. 2(a) . The CTC-chip consisted of an array of microposts that were functionalized with anti-epithelial-cell-adhesion-molecule (EpCAM) antibodies. EpCAM is frequently overexpressed on carcinomas but is absent from haematologic cells, thus anti-EpCAM provides the specificity for CTC capture from unfractionated blood. The results showed that the CTC-chip could effectively identify CTCs in 115 of 116 (99%) clinical metastatic cancer patients, with a range of 5∼1,281 CTCs per milliliter and approximately 50% purity. The chip captured viable CTCs in a single step from whole blood without pre-dilution, pre-labeling, pre-fixation or any other processing steps, making it a potential strategy for automated cell isolation. By changing the antibodies coated on the microposts, other types of rare circulating cells can be isolated in the blood. In 2010, researchers from the same team developed a robust microfluidic chip for rapidly isolating neutrophils from whole blood [57] , as shown in Fig. 2(b) . CD66b-specific monoclonal antibodies were covalently linked to the surface of the channel of microfluidic devices. Neutrophils express CD66b and thus were specifically bound to the surface. The research significantly reduced the isolation time and the sample volume, from about an hour and milliliters of blood to a few minutes and only microliters of blood, demonstrating the promising role of microfluidics in automated cell isolation. In 2015, Wang et al. [58] developed a new method capable of simultaneous CTC capture and detection by integrating a microfluidic silicon nanowire (SiNW) array with multifunctional magnetic upconversion nanoparticles (MUNPs). The MUNPs were labeled with anti-EpCAM antibody, thus can specifically recognize tumor cells in the blood samples and pull them down in an external magnetic field. The captured cells can be conveniently collected from the microfluidic device for further analysis or cell culture.
The methods of microfluidic cell isolation in [56] [57] [58] rely on the specific cell surface markers of target cells and thus have high specificity, but also accompanied with increased difficulty in subsequent cell collection (difficult to collect CTCs binding to the surface of channels in biological microfluidic [56] , [57] ) and decreased fidelity of cell (magnetic particles retain on the surface of CTCs in magnetic microfluidic [58] ). Recently researchers have been developing label-free microfluidic methods for CTC isolation by utilizing physical properties of cells (such as size, density, stiffness, deformability, compressibility, surface properties, electrical polarizability, magnetic susceptibility, and refractive index [59] ). In microfluidics with micrometer sized channels, the Reynolds number is typically small and inertial effects are often neglected. However, at modest channel dimensions or velocities, inertial effects manifest and can be exploited for cell sorting [50] . Cells with differing properties such as size, density, or shape respond differently to inertial effects and are focused at different channel locations. In 2014, Warkiani et al. [60] reported a novel spiral microfluidic device with a trapezoidal cross-section for ultra-fast, label-free enrichment of CTCs from clinically relevant blood volumes, as shown in Fig. 2(c) . The lysed blood was pumped through the spiral chip using a syringe pump. CTCs were focused near the inner wall due to the combination of the inertial lift force and the Dean drag force at the outlet, while white blood cells and platelets are [60] , [61] External excitation force Label-free, fidelity of cell Low throughput, high cost [62] , [63] trapped inside the core of the Dean vortex formed closer to the outer wall. CTCs have a diameter that is three to four times as large as the bores of capillaries in distant organs, so they would be expected to become trapped there [54] . In 2014, by utilizing the characteristic physical property that CTCs are significantly larger than healthy haematologic cells in blood, Huang et al.
[61] developed a size-based microfluidic chip, which exploits filtration microchannels to isolate the relatively larger CTCs from the rest of the blood constituents, as shown in Fig. 2 
(d).
CTCs were detected in 96.7% of patients with the mean number of 18.6 cells per milliliter. Because the methods in [60] , [61] do not rely on cell surface expression markers, the captured CTCs can be readily collected for further downstream analyses (e.g., detection). However, the specificity of size filtration is relatively low due to the possible overlap in cell sizes between CTCs and blood cells, making it not applicable to all sample types [59] . In recent years, researchers have investigated microfluidics label-free cell isolation method by actively applying excitation forces. In 2015, Li et al. [62] developed an acoustic-based microfluidic device that was capable of separation of CTCs from peripheral blood samples obtained from patients with breast cancer, as shown in Fig. 2(e) . The acoustic waves are generated by interdigitated transducers (IDTs) which are patterned on a piezoelectric substrate and then mounted to a microfluidic device. Cells with different physical properties experience different amplitudes of the acoustic radiation force, which enables the separation of these cells. The advantage of acoustic method is that it is noninvasive and has no impact on the viability, function, and gene expression of cells. However, this method require wavelengths comparable to microfluidic channel width, and therefore the sorting rate cannot be increased because the wave frequency is constrained [50] , resulting the low throughput. In 2013, Huang et al. [63] presented a CTC isolation method by combining microfluidic with optically-induced electrophoretic (ODEP) technique, as shown in Fig. 2(f) . The ODEP force exerting on a cell is dependent on its size and dielectric property. By adjusting the velocities of moving lightbars, cancer cells were gradually pulled out into the buffer flow as the sample passed through the separation region. The advantage of this method is label-free, but the throughput is low and the cost of chip fabrication is relatively high. All together, the CTC isolation methods based on microfluidics described above (summarized in Table I ) enable automated collection of cancer cells from clinical patients.
After obtaining an enriched cancer cell suspension from clinical samples, the next step is to isolate single cells from one another and then deliver them to the micro/nano automation pipeline one by one for the subsequent robotic manipulations of discrete individual cells. In 2006, Di Carlo et al. [64] presented a hydrodynamic trapping method using U-shaped obstructions to physically isolate single cells on a chip, as shown in Fig. 3(a) . The trap size biased trapping to predominantly one or two cells. No surface modification was required and cell loading was done in less than 30 seconds. In 2009, Wang et al. [65] developed a negative pressure method for the immobilization of single embryos, as shown in Fig. 3(b) . Evenly spaced through-holes were connected to a vacuum source via a backside channel. Upon dispersing a batch of embryos onto the device, a sucking pressure enabled each through-hole to trap a single embryo. The extra non-trapped embryos were flushed away from the device. In 2015, Formosa et al. [66] presented an immobilization method based on polydimethylsiloxane (PDMS) lithography, which could effectively trap microbial cells from spores of bacteria to yeast cells, as shown in Fig. 3(c) . The method involved three sequential stages, including generation of a microstructured silicon master, PDMS stamp molding, and assembly of living cells into the PDMS stamps. In 2012, Wang et al. [67] used the similar method (PDMS-based microwells) to immobilize mammalian cells. The PDMS microwell array was treated by oxygen plasma for 30 s to render its surface hydrophilic. After dropping cell solution onto the chip, cells could land into the microwells under the influence of gravity. Our group have developed a micropillar method for trapping mammalian suspended cells [68] , as shown in Fig. 3(d) . The fabricated silicon micropillar chip was coated by a layer of poly-L-lysine. With [76] , [77] . (c) Indenting single cell to acquire cellular mechanical properties [87] . (d) Locating individual target molecule on cell surface [93] . (e) Nanodissection of filaments in live keratinocyte [39] . (f) Delivering (injecting) drug molecules onto (into) single cells by combining nanomanipulator with microfluidics [38] .
this method, lymphoma cells were immobilized both horizontally (pillar trapping) and vertically (poly-L-lysine electrostatic adsorption) and then AFM images of living cells were obtained. The methods described above [64] [65] [66] [67] [68] physically trap single cells in an orderly pattern, showing the potential to perform robotic manipulations on individual cells one by one.
For the goal of automatically detecting cancer cells for drug susceptibility test, conveyor system is needed. Chips containing the arrays of units (such as the U shaped structure [64] , throughhole [65] , microwell [66] , [67] , and micropillar [68] ) that can trap single cells may be fabricated. After trapping cells, the chip is loaded onto the conveyor system and the cells on the chip are manipulated by micro/nano robots and micro/nano manipulators. There may be many micro/nano robots and micro/nano manipulators in the pipeline and each performs a specific task, such as detecting the cellular viability, injecting drugs into the cell, indenting the cell, dissecting and visualizing the cellular structures. Also conveyor system containing the units that can trap single cells may be directly fabricated. As the trapped cells move along with the conveyor system, micro/nano robots and micro/nano manipulators perform manipulations on the cells. In 2005, Chiou et al. [69] presented a conveyor system for single cells based on ODEP technology. Cells were trapped in light-patterned electrodes. By programming the projected lighpatterned electrodes, the trapped cells could be moved in parallel to specific places. The research provides a new idea for developing automated conveyor system of single isolated cells. The next issues needing to be addressed are the integrations, such as the integrations between the microfluidics-based primary cell isolation system and the conveyor system, and the integrations between the conveyor system and micro/nano robots or micro/nano manipulators. It should be noted that the drawback of microfluidics is that microfluidic devices are not readily reusable due to clogging and cell adhesion [50] , posing a challenge when large quantities of cells are treated. Collectively, microfluidics has the potential to work as an important building block for automated cell isolation and delivery systems, which may play an important role in micro/nano automation for personalized medicine.
IV. AUTOMATICALLY ACQUIRING CELLULAR FEATURES
After the process of automated cell isolation and delivery, the next step is to perform robotic detections on cells for drug evaluation, meaning that micro/nano robots or micro/nano manipulators need to automatically acquire and quantify the cellular properties and their changes after the drug stimulation. In the past decade, the applications of nanomanipulator in cell detection contribute much to the field of microscale and nanoscale robotic medicine, providing new possibilities for quantitatively characterize the cellular behaviors at the single-cell and singlemolecule levels. Fig. 4(a) shows the configuration of a typical AFM-based nanomanipulator developed by our group [37] . Using the augmented reality environment, the operator senses the real-time contact force between the nano-object and end effector and also watch the real-time AFM images of the nanomanipulation. The operator determines the next manipulation strategy based on the haptic and visual feedback results. Cell detection by traditional biochemical methods requires diverse pretreatments of cells, such as fixation, labeling, lysis, and staining [70] , destroying the natural structures of cells and can only provide static information [71] . In contrast, cell detection by micro/nano robots and micro/nano manipulators is label-free, allowing us to real-time monitor the behaviors of single cells without interrupting their normal courses, which is of important significance in uncovering the dynamic character of cellular activities.
By scanning the local areas on the cellular surface with AFM nanomanipulator, the detailed topography of single cells at the micro/nano scale can be obtained. Cell surface nanostructures is closely related to cellular functions, for example, the normal cells have brushes (consisting of microvilli, microridges and cilia) of one length, whereas cancerous cells have mostly two brush lengths of significantly different densities [72] . A recent study showed that AFM can reveal the individual microvilli on living cells [73] , demonstrating the huge potential of AFM visualization in medicine at the nanoscale. The prerequisite of detecting cellular properties using nanomanipulator is immobilizing cells onto the substrate. Adherent cells can naturally grow and spread on the substrate, and thus they can be directly handled after being cultured on substrates. Cells are negatively charged. For microbial cells which have stiff cell wall, by coating substrates with poly-L-lysine (positively charged) [74] , cells can be immobilized onto the substrate by electrostatic adsorption. Also porous polymer membrane [75] has been used for mechanically immobilizing microbial cells. The sizes of pores in the polymer membrane are comparable to the sizes of microbial cells. When pushing cell suspensions to pass through a porous polymer membrane, the pores can trap single cells. For mammalian suspended cells whose sizes are significantly larger than that of microbial cells, there are no commercial porous polymer membranes. In order to visualize the topographical ultra-microstructures of living mammalian suspended cells, our group have presented an immobilization method combining micro-fabricated pillar mechanical trapping with poly-L-lysine electrostatic adsorption [68] . Based on the immobilization method, the ultra-microstructures of single living lymphoma cell were imaged by nanomanipulator and further the dynamic changes of ultra-microstructures on cellular surface were revealed after the stimulation of rituximab molecules [76] , [77] , as shown in Fig. 4(b) . Fig. 4(b) (i, ii) are the AFM images of local areas on single lymphoma cell surface before (i) and after (ii) rituximab stimulation. The inset in Fig. 4(b) (i) is the AFM image of the whole cell. Fig. 4(b) (iii, iv) are the AFM images of whole lymphoma cell (iii) and local areas (iv) after rituximab-induced complement-mediated cytotoxicity. The results visually improved our understanding of rituximab's actions. From the AFM images, the roughness of cell surface can be calculated [77] , which can be used to quantitatively characterize the properties of cell surface. Strict roughness analysis requires the very flat surface. However, cell surface is not flat but has a curvature, which influences the results of roughness calculated from AFM images. Hence, how to eliminate the interference of cellular curvature is a problem needing to be solved in the quantitative characterization of cellular surface topography.
By indenting the cell, AFM-based nanomanipulator can acquire the mechanical properties of cells. Cell mechanics plays an important role in modulating the physiological behaviors of cells, such as tumor metastasis [78] . During tumor metastasis, a cancer cell must detach from the primary tumor, invade through local tissue, squeeze into blood or lymphatic vessels, survive the harsh conditions within those vessels, squeeze out of them, and begin growing in a new tissue [79] . These series of behaviors of cancer cells during metastasis are closely related to their mechanical properties, such as deformability, adherence, and locomotion [49] . In 2012, a comprehensive study by Plodinec et al. [80] revealed that there were significant differences in the stiffness profiles of breast tissues during the development of breast cancer, demonstrating the active role of detecting cellular mechanical properties in cancer diagnosis. The past decade has seen the great potential of detecting cell mechanics in labelfree evaluating drugs at the individual cell level [81] , [82] . The elastic and viscous properties of single cells can be measured by AFM nanomanipulator at the approach-retract mode. At this mode, the AFM tip is firstly controlled to vertically indent the cell. When the maximal loading force set in advance is achieved, the tip withdraws from the cell surface. During the approachretract process, the so called force curves are recorded. Cellular Young's modulus is extracted by fitting the force curves with adequate mechanical models. There are several models for extracting cellular Young's modulus from the recorded force curves, including Hertz-Sneddon model, Johnson-Kendall-Roberts (JKR) model, Derjaguin-Muller-Toporov (DMT) model, and OliverPharr model [83] . Hertz model is suited for spherical tip, and Sneddon extended it to conical tip. In practice, due to the simpleness and effectiveness, the most widely used is Hertz-Sneddon model [84] . Notably, Hertz-Sneddon model is based on a number of assumptions, including homogeneity, isotropicity, linear elastic material properties, axisymmetry and infinitesimal deformation of the sample, as well as infinite sample thickness and a smooth sample surface, but studies have shown that HertzSneddon is appropriate as long as the indentation depth is less than 10% of the thickness of cell [85] . The viscoelastic properties of cells can be measured by stress relaxation test [86] during which the tip resides for a period of time after it indents the cell. By fitting the stress relaxation curve with mechanical models (such as two Maxwell elements model [87] ), the relaxation time of cell is extracted. We have applied AFM nanomanipulator to investigate the viscoelastic properties (Young's modulus and relaxation time) of primary cells from lymphoma patients (as shown in Fig. 4(c) ) and the results indicated that there are significant differences in viscoelastic properties between normal lymphocytes and lymphoma cells, demonstrating the potential of AFM in measuring the mechanical properties of human primary cells. The measurements of the mechanical properties of cells by AFM reveal the cellular mechanical phenotypes [88] , which can be used to discriminate cancer cells from their normal counterparts [89] and thus indicate the cell states. From a medical perspective, insights into the biomechanical changes that occur during tumor progression may lead to novel selective treatments by altering tumor cells' mechanical properties [90] . Such drugs would probably not cure by killing cancer cells, but may effectively hinder the propagation of the tumor.
Knowledge of drug-target interaction is critical for our understanding of drug actions. Larger drug-target binding force means that the drug molecules can retain themselves on the cell surface and induce biological actions for more time. While the larger density of target molecules on the cell surface can recruit more drug molecules to attack the cell. Hence, probing the single target molecules on cell surface is of great significance in evaluating drug efficacies. In order to enable nanomanipulator to probe the drug-target interaction on cell surface, the tip needs to be functionalized with drug molecules. There are three main methods for tip functionalization: protein physisorption, chemisorption of alkanethiols on gold, and covalent coupling of silanes on silicon oxide [91] . The drawback of protein physisorption is that it often exhibits many molecular binding events during the measurement, while the alkanethiol chemisorption requires previously coating the tip with a layer of gold and thus decreases the spatial resolution of tip [92] . The covalent coupling method is performed directly on a silicon tip without gold coating, and the binding strength of a covalent bond is much stronger than that of physisorption or chemisorption, making it very suited for probing individual drug-target interactions. By functionalizing the AFM tip with rituximab, our group have applied nanomanipulator to probe the drug-target interactions directly on the tumor cells prepared from clinical lymphoma patients at the single-molecule level [93] , as shown in Fig. 4(d) . Rituximabs were linked to the AFM tip via NHS-PEG-MAL molecules. By controlling the tip to indent the cell and retract, force curves are recorded. During the contact between tip and cell, if drug molecule on the tip bind to the target molecule on the cell surface, drug-target complex is pulled when the tip is retracted. When the pulling force exerted on the probe is larger than the binding force between drug molecule and target molecule, the drug-target complex ruptures and a specific unbinding peak occurs in the retract curve. By controlling the density of drug molecules attached to the tip to a low level, it can be ensure that only one drug-target pair forms during one measurement. Thus, the specific unbinding peak in the retraction curve corresponds to the event of a drug-target pair and the magnitude of the peak is equal to the unbinding force of one drug-target pair. By obtaining arrays of force curves using the functionalized tip, the distributions of target molecules on the cell surface can then be quantitatively mapped [94] . By probing the individual target molecules on cancer cells, the relationship between the target's information (binding affinity and distribution) and the clinical therapeutic outcomes can be established, which may then potentially be used for predicting the efficacies of drugs for each patients.
Surgery is a centuries-old medical technique that uses tissue/organ specific physical intervention to treat illness. By AFM nanomanipulator, surgery can be performed on single living cells with nanometer precision [39] , as shown in Fig. 4(e) . Our group have successfully dissected the cellular connection by severing the intermediate filaments underneath the cell membrane. The filament structures were dissected as indicated by the height decrease in the section profiles. The subsequent mechanical analysis revealed that the adhesion loss resulted in a decrease in cellular elasticity. Recently, Guillaume-Gentil et al. [38] have combined AFM manipulator with microfluidics to controllably manipulate single cells, as shown in Fig. 4(f) . A microchanneled cantilever was connected to a pressure controller via a fluidic circuit. The diameter of the aperture was 300∼400 nm. Individual bacterial, yeast and mammalian cells can be immobilized at the probe aperture by applying underpressure. Then the cells can be transported and released at a desired location by reversing the pressure. Besides, femtoliter volumes of a solution loaded in the microchannel can be delivered locally to the cell (if the target is expressed on the cell surface) or directly injected into the cell (if the target is inside the cell), providing potential solutions for drug delivery in single-cell micro/nano automation technology. The method can also be used to detect the viability of cells by delivering dyes (such as trypan blue and propidium iodide) to cells.
It can be anticipated that single-cell micro/nano automation pipeline is a small plant, in which individual cells are loaded on the conveyor system one by one and then manipulated by various micro/nano robots and micro/nano manipulators. These robots automatically perform different tasks, including detecting the viability of cell, delivering (injecting) drugs to cell, visualizing the ultra-microstructures and locating the individual target molecules on the cell surface, indenting the cell to acquire cellular mechanical properties, dissecting the local parts of cell, picking the cell from the conveyor system and placing it in another site, and so on, as shown in Fig. 4 . However, it should be noted that current manipulations by AFM-based nanomanipulator require much manual labor. For example, in acquiring the mechanical properties of single cells, the AFM tip is navigated to the target cell by manually observing the optical image and moving the sample stage. Then the tip indents the cell and records force curves by manually setting the parameter, such as loading force and loading rate. After the measurements, the force curves are processed offline manually to extract mechanical parameters of cells (such as Young's modulus, relaxation time). Although the recent developments in AFM, such as peak force quantitative nanomechanical mapping (QNM) technology [95] , integrate data processing and enable real-time visualization of cellular mechanical properties. QNM is mainly used for certain types of cells which have relative stiff surface, including microbial cells [96] and some specific mammalian adherent cells such as keratinocyte [97] . So far applying QNM technology to handle living mammalian suspended cells is still challenging, which limits the applications of QNM.
In order to achieve automated cellular handling, several issues should be solved. The first issue is automatically moving the AFM tip to the specific positions of cell. For example, during measuring the cellular mechanical properties, AFM tip is controlled to indent the central area of the cell to decrease the influence of substrate [98] . Cells are loaded on the conveyor system in well-defined patterns, and thus it can be programmed to make nanomanipulator automatically approach the cells. Then the nanomanipulator should recognize the central area of the cell. However, cells are heterogeneous and have different properties (size, shape). For example, suspended cells (such as blood cells) are often round, while adherent cells (such as breast cells and nerve cells) are often irregular [99] . Hence, adaptive methods are needed to exactly help the nanomanipulator to locate the central area of the cell. The second issue is automatically changing the tip. During manipulations, the wear and tear of tip can inevitably occur, which will influence the precision of manipulations. For example, in probing molecular interactions, the functionalized tip can probably lower activities after measurements due to tip contamination (such as the unspecific molecular interactions) [95] , [100] . In addition, in some applications, specific tips are required. For example, in measuring cellular mechanical properties, often sphere tips are needed to characterize the whole mechanical properties of cells [101] . Hence, methods that can recognize the tips which should be changed and can then automatically mount the new tips are needed. The third issue is the intelligent control and communication of massive micro/nano manipulators. In 2012, Xie and Regnier [35] presented a double nanomanipulator system. Image scan and nanomanipulation can be performed in parallel through the collaboration between two cantilevers: one cantilever acts as an imaging sensor and the other is used as a manipulation tool. In 2013, Diller et al. [102] presented a method to independently control three microrobots in three dimension (3D) based on magnetic gradient, allowing for different magnetic forces to be exerted on each independent motion control and path following of three microrobots along arbitrary 3D trajectories. The control was demonstrated for a wide range of fluid viscosities of interest in potential microfluidics and medical applications. However, because of the coupled nature of the magnetic actuation, it is not suitable for truly independent control of large number of microrobots [103] . In the single-cell micro/nano automation pipeline, the situations will be much more complex: many micro/nano robots or micro/nano manipulators work together with different tasks and the objects (cell) being handled are heterogeneous. So far, there has not been a single approach that can address the problem of independent control of a large team or swarm of microrobots and more systematic approaches of control are needed [103] . Addressing these issues are essential to realize the micro/nano automation system for automatically acquiring cellular features.
V. DATA ANALYSIS
After obtaining the quantitative cellular features by robotic manipulations, the next step is to reveal the biological information (e.g., cellular functions, cellular states) underneath these parameters. This requires establishing the relation models between the parameters acquired by robotic manipulations and cellular functions in advance. Ideally, the parameters are inputted into a database, in which the cellular biological functions are automatically mapped according to the built-in relation models. Hence, the prerequisite is to create such a database for a particular type of cancer. Taking B-cell non-Hodgkin lymphoma as an example, some patients are sensitive to the therapy of rituximab and also some patients are not sensitive to therapy of rituximab [8] . Generally speaking, it requires selecting a number of clinical B-cell non-Hodgkin lymphoma patients. B-cell nonHodgkin lymphoma contains many subtypes, including small B-cell lymphocytic lymphoma, follicular lymphoma, mantlecell lymphoma, marginal-zone lymphoma, diffuse large B-cell lymphoma, and Burkitt's lymphoma [104] . The lymphoma subtypes of the selected patients can be confirmed by pathological assay, including cell morphology, immunophenotype, and genetic features [105] . For each patient, before the clinical therapy, the primary lymphoma cells from the patient can be isolated using the method based on microfluidics (Fig. 2) . The cells are then delivered to the micro/nano automation pipeline and manipulated by micro/nano robots and micro/nano manipulators.
The cellular features (e.g., cell surface, elasticity, viscosity, adhesion force, target affinity and distribution, as shown in Fig. 4 ) are recorded. The cellular biological functions (e.g., proliferation, viability, deformability, adherence, and locomotion [49] ) are also probed and recorded by nanomanipulator. For example, staining molecules inject can be injected into cells to detect the viability of cells [38] , [106] , and the adhesion of cells can be measured by single-cell force spectroscopy [107] . Then the relations between cellular features and cellular functions can be mapped. Also the changes of cellular features and cellular functions after the stimulation of drugs are recorded, which is useful for evaluating drugs. Our goal is ultimately evaluate the drug efficacies on individual patients for personalized medicine. Hence, the data of clinical outcomes are collected. The selected patients receive the clinical rituximab therapy and the therapeutic outcomes are recorded. The recorded results provide the original source for establishing a database, in which different types of relations can be mapped, such as the relations between cellular functions and drug effects (clinical outcome), the relations between cellular features and drug effects. Due to the complex of cancers, investigating the cancers from multiple facets (such as cellular features, cellular functions, and clinical efficacies) may help us to better understand cancers. Notably, an issue needing to be clarified is whether the process of acquiring cellular features can influence cell states (for examples, cells are indented for measuring cellular mechanical properties). Besides, the measurement conditions should be maintained identical (for example, the loading force and loading rate of tip during the mechanical measurement should be fixed) to make sure that the results are comparable for different patients. The database increases as more patients are tested. With the established database, potential biomarkers that can be used to predict the efficacies of drugs for each cancer patients may be recognized.
For practical applications, only small clinical samples should be required (such as a tube of blood extracted from the patient) to judge whether the patient is sensitive to the therapeutic drugs. However, cancer cells are highly heterogeneous [108] , [109] . Hence the question is how to confirm that the information obtained on small cancer cells can truthfully characterize the feature of large cancer cells of the patient. Besides, in clinical practice, targeted drugs are often combined with chemotherapy drugs (for example, rituximab is commonly combined with CHOP chemotherapy agents [110] ). There are significant differences in cell behaviors between in vivo and in vitro environments. Hence how to handle and detect cancer cells with combined drugs in vitro and simultaneously mimic the in vivo environments needs to be addressed.
VI. DISCUSSION AND PERSPECTIVE
By integrating the three parts, including automated cell isolation and delivery, automatically acquiring cellular features, and data processing, a prototype of the micro/nano automation system for drug susceptibility test of individual patients may be constructed. To some extent, traditional fluorescence-based flow cytometry which have been successfully applied to clinical problems [70] is like such a prototype. Ideally, for widespread use, this system is fully automated without any manual intervention. The samples from clinical patients are collected and then inputted into the micro/nano automation system without any pretreatments. The system can automatically isolate the target cells (such as CTCs), perform robotic manipulations on them, and display the results (e.g., whether the patients can obtain benefits from the drugs).
For constructing the micro/nano automation system, the integrations between the various parts of the system will influence the performance of the system. In 2008, Adamo et al. [111] developed an approach for single cell microinjection by integrating a microneedle onto the microfluidic chip. In 2012, Delubac et al. [112] presented an improved method, allowing automatically retrieve embryos from an external reservoir, separate and align clustered embryos, push the embryos onto the injector, and eject the embryos to an external reservoir. An external camera triggered the injection of reagents by detecting the embryos at the injection position. The research [111] , [112] provides a new idea to integrate cell delivery and robotic manipulations in micro/nano automation system. ODEP-based cell trapping technology [69] offers the potential for the single-cell conveyor system. For the conveyor system, a notable issue is the interactions between cells and the conveyor system. Suspended cells (e.g., hematological cancer cells [41] ) do not adhere to the substrate and thus can be transported easily. While for adherent cells (e.g., breast cancer cells [80] ), they can grow and spread on the conveyor belts, which will influence the subsequent robotic manipulations (for example, picking cells from the conveyor belt). Hence, how to cleverly integrate conveyor system with robotic manipulations will be of active significance for the realization of micro/nano automation system.
In recent years, researchers are pursuing fabricating micro/nano robots for biomedical applications. At the microscale, artificial machines have been investigated, such as the micromotors driven by diverse methods, including ultrasound propulsion, magnetic propulsion, bubble propulsion, and selfelectrophoretic propulsion [30] . At the nanoscale, biological molecules have been used to construct molecular robots, for example, motor proteins such as actin-myosin system have been proposed as the building blocks of molecular actuators, and DNAs have been used to develop molecular sensor [113] . The developments of micro/nano robots will play an important role in the progress of micro/nano automation technology.
Another important direction will be the relation research between the label-free physical information (e.g., cell surface, elasticity, viscosity, adhesion force, target affinity and distribution) of single cells detected by nanomanipulators and the pathological changes of cellular functions in the clinic. The procedures of clinical sample preparation and robotic measurements need to be standardized, and the related thresholds of cancer cells (such as value ranges of normal cells, and value ranges of cancer cells) need to be confirmed. Besides, tumor formation is the co-evolution of cancer cells together with the microenvironments of cancer cells [109] . The microenvironments (e.g., non-cancer cells, extracellular matrix, and vasculatures) play an crucial role in the behaviors of cancer cells, such as metastasis [114] . Consequently, a challenge is how to quantitatively characterize the influence of microenvironments of cancer cells on the clinical efficacies of drugs. In addition, although evidence has shown the close link between cellular mechanical properties and cancer formation [80] , the underlying molecular mechanisms guiding this link are still unknown [115] , posing a challenge to the in-depth research of the role of cell mechanics in cancer development. Addressing these challenges will be of great significance in realizing micro/nano automation system for personalized medicine.
VII. CONCLUSION
The achievements of micro/nano robotics in the past decade enable handling single living cells with nanometer resolution, which holds much promise for improving the automation level of current drug susceptibility test in the clinic. While the potential significance of single-cell micro/nano automation technology in broad fields (biology, medicine, engineering, automation, manufacture, etc) is clearly evident, the creation of a fully single-cell micro/nano automation system remains a grand challenge. We have reviewed here some related progress and technical challenges involved in single-cell micro/nano automation technology, including automated cell isolation and delivery, automatically acquiring cell properties, and data analysis. With so many challenges to be addressed, practically usable single-cell micro/nano automation system may not come true in the future for a long period of time. Nevertheless, proof-of-concept study is the first crucial step toward such a system, which will require the cooperative efforts between researchers from different disciplines. Overall, applying micro/nano automation technology to detect cancer cells for personalized medicine is in its infancy, and we have much to look forward to as it grows.
